fashion -WSS

fashion

author：explore 2025-09-27 12:22:33 - browse：989

Illustraion of an abstract genome figure made of dots. -- health coverage from STAT — Adobe

LONDON — A decade ago, the U.K. launched its 100,000 Genomes Project, a major research endeavor that involved sequencing the DNA of that many people to discover how our genes shape our health.

But the initiative wasn’t just focused on sequencing our regular DNA. One arm of the project also entailed decoding the genomes of some participants’ tumors.

In a paper published Thursday morning in the U.K., researchers reported their findings from more than 13,800 solid tumors in adults, detailing that certain tumors were more likely to carry mutations that could inform patient care, whether by steering treatment choices or indicating a potential familial risk. The findings are already influencing clinical practice: It’s becoming standard for patients in the National Health Service with those tumors — including types of brain cancers, sarcomas, and ovarian cancers — to get their tumors sequenced.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Oak Street deal isn't the answer to health care's woes

WSS

Altering the blood type of lungs raises potential for universal organs for transplants

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Novo pauses ads for weight loss drug Wegovy amid demand

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Mom launches Girl Scout troop for LGBTQ youth in Texas

FDA approves first new drug developed for postpartum depression

entertainment

fashion

hotspot

Drug repurposing or repositioning? The language matters

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Affirmative action in medical school literally saved lives

Novo pauses ads for weight loss drug Wegovy amid demand

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Supreme Court to hear if Covid misinformation is protected speech

How to save PrEP access — and even expand it

Bispecific antibodies are next new thing in cancer immunotherapy

After affirmative action ruling, medical educators look to 'holistic review'

FDA approves first new drug developed for postpartum depression

hotspot

Oak Street deal isn't the answer to health care's woes

Free medical tuition alone isn't enough to close gaps in primary care

As H5N1 spreads in cows, experts warn against drinking raw milk

Free medical tuition alone isn't enough to close gaps in primary care

Obesity drug from Roche shows promise in early study

Abbott's new stent may help patients with peripheral artery disease

leisure time

hotspot

leisure time

explore